Figure 2

Estimated HAV seroprevalence by age group in 2000 and 2030 (upper panel); the estimated proportion of the population with HAV immunity between 2000 and 2030 for selected age groups (lower panel).
Estimated HAV seroprevalence by age group in 2000 and 2030 (upper panel); the estimated proportion of the population with HAV immunity between 2000 and 2030 for selected age groups (lower panel).